----item----
version: 1
id: {51646E13-EE4C-4D81-8735-6CBC5283042C}
database: master
path: /sitecore/content/ScripIntelligence/Home/Articles/2015/11/03/Actelion boosted by selexipag data
parent: {9A22D265-E46B-490A-8BDC-BA644F0271DB}
name: Actelion boosted by selexipag data
master: {00000000-0000-0000-0000-000000000000}
template: {11380B5D-3531-4570-B213-EFC5312266E4}
templatekey: Article

----version----
language: en
version: 1
revision: bfa8a189-7863-4417-b568-fa4a63917dc2

----field----
field: {0212FC0F-953B-461C-B4D9-B7483A4D4F1B}
name: Taxonomy
key: taxonomy
content-length: 194

{4405059F-46BF-48C9-BCF4-B14E77639FB3}|{864F8DF2-858F-4FE1-9E65-EFCEEBFA8288}|{CD796374-A60A-4D81-8A05-7B92AD2013C1}|{3FA7743D-5DAB-49A3-B30D-DF5079ADB082}|{29C8E5B9-B01E-4DEE-A123-14D70756095B}
----field----
field: {2D750EFF-9058-4ABF-A7FF-57FFE5DA1E3C}
name: Title
key: title
content-length: 34

Actelion boosted by selexipag data
----field----
field: {F1D1DC93-63DF-4AFA-B60F-B3A3E9D36675}
name: Sub Title
key: sub title
content-length: 34

Actelion boosted by selexipag data
----field----
field: {446A339B-E1D9-4DE1-8B5E-DB7942EF1723}
name: Body
key: body
content-length: 2079

<p>Actelion's share price closed up by 2.45% at CHF117.00 on 16 March after the firm announced positive long-term outcome data from a pivotal trial of its investigational oral prostacyclin agonist selexipag for pulmonary arterial hypertension (PAH). The data from the 1,156-patient Phase III GRIPHON study showed that selexipag reduced the risk of a morbidity/mortality event by 40% versus placebo (p<0.0001) in="" patients="" with="" pah.="" 80%="" of="" patients="" were="" already="" receiving="" therapy="" for="" pah,="" either="" an="" endothelin="" receptor="" antagonist,="" a="" phosphodiesterase-5="" inhibitor="" or="" both.="" treatment="" with="" selexipag="" also="" led="" to="" a="" statistically="" significant="" increase="" in="" six-minute="" walking="" distance="" at="" week="" 26="" of="" 12="" meters="" over="" the="" entire="" population="" (p="0.0027)" with="" an="" improvement="" of="" 34="" meters="" in="" pah-treatment-naive="" patients="" (p="0.0002)" but="" only="" 7="" meters="" for="" patients="" on="" other="" therapies.="" biomedtracker="" raised="" its="" likelihood="" of="" approval="" by="" two="" percentage="" points="" to="" 91%,="" six="" points="" higher="" than="" average="" at="" this=""></0.0001)></p><p><b>Related <i>Scrip </i>stories:</b></p><p><a href="http://www.scripintelligence.com/researchdevelopment/Actelion-files-PAH-drug-in-US-355847" target="_new">Actelion files PAH drug in US</a></p><p><a href="http://www.scripintelligence.com/researchdevelopment/Actelion-files-new-PAH-treatment-Uptravi-355426" target="_new">Actelion files new PAH treatment Uptravi</a></p><p><a href="http://www.scripintelligence.com/researchdevelopment/Actelions-high-potential-in-hypertension-has-United-Therapeutics-on-ropes-352360" target="_new">Actelion's high potential in hypertension has United Therapeutics on ropes</a></p><p><a href="http://www.scripintelligence.com/home/FDA-OKs-United-Therapeutics-oral-PAH-drug-Orenitram-on-3rd-try-348968" target="_new">FDA OK's United Therapeutics oral PAH drug Orenitram on 3rd try</a></p><p>
----field----
field: {5BA0578F-65B7-4C22-8233-1603D698D8A4}
name: Summary
key: summary
content-length: 423

<p>Actelion's share price closed up by 2.45% at CHF117.00 on 16 March after the firm announced positive long-term outcome data from a pivotal trial of its investigational oral prostacyclin agonist selexipag for pulmonary arterial hypertension (PAH). The data from the 1,156-patient Phase III GRIPHON study showed that selexipag reduced the risk of a morbidity/mortality event by 40% versus placebo (p<0.0001)></0.0001)></p>
----field----
field: {8F4EE718-6FA0-42A5-85C4-6C8FE8B1FCD4}
name: Navigation Title
key: navigation title
content-length: 34

Actelion boosted by selexipag data
----field----
field: {7C4FC796-1311-4DAA-81AC-85EAA2C1C108}
name: Actual Publish Date
key: actual publish date
content-length: 15

20151103T160000
----field----
field: {BDF7C8E1-869E-49FF-B9F5-854B3081A45D}
name: Created Date
key: created date
content-length: 15

20151103T160000
----field----
field: {C926A72A-39DA-446D-B78C-2A650F820A73}
name: Modified Date
key: modified date
content-length: 15

20151103T160000
----field----
field: {1616FE67-7278-4169-948E-C29B00EC8781}
name: Article Number
key: article number
content-length: 8

SC028132
----field----
field: {2C985172-2B37-4CFE-AEDE-2A42EC833941}
name: Content Type
key: content type
content-length: 38

{832554E5-EC9E-4747-8623-6770D36CAF32}
----field----
field: {31603F25-6D9C-4954-BCDE-342E1E184A30}
name: Meta Title Override
key: meta title override
content-length: 34

Actelion boosted by selexipag data
----field----
field: {53288D3D-66D7-4ACE-B3E4-D7D02B1F3672}
name: Referenced Companies
key: referenced companies
content-length: 9

199800318
----field----
field: {AE1BD751-D4E7-49CB-96C4-62E995A06B51}
name: Article Category
key: article category
content-length: 13

Headline News
----field----
field: {0F6C8F42-01DC-4E05-B63E-AA25D8AA0E09}
name: Legacy Publication
key: legacy publication
content-length: 38

{0F9CCE10-91C1-4F31-832A-266F482A5DAF}
----field----
field: {5795FF15-0942-41FF-8A77-3B73185F5E1B}
name: Escenic ID
key: escenic id
content-length: 6

357232
----field----
field: {25BED78C-4957-4165-998A-CA1B52F67497}
name: __Created
key: __created
content-length: 16

20160209T042311Z
----field----
field: {5DD74568-4D4B-44C1-B513-0AF5F4CDA34F}
name: __Created by
key: __created by
content-length: 18

sitecore\Anonymous
----field----
field: {8CDC337E-A112-42FB-BBB4-4143751E123F}
name: __Revision
key: __revision
content-length: 36

bfa8a189-7863-4417-b568-fa4a63917dc2
----field----
field: {D9CF14B1-FA16-4BA6-9288-E8A174D4D522}
name: __Updated
key: __updated
content-length: 16

20160209T042311Z
----field----
field: {BADD9CF9-53E0-4D0C-BCC0-2D784C282F6A}
name: __Updated by
key: __updated by
content-length: 18

sitecore\Anonymous
